Norbert Ifrah

23.3k citations

231 papers · 11.4k · 2 hit papers · h-index 52

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 147
- Acute Myeloid Leukemia Research 92
- Chronic Myeloid Leukemia Treatments 44
- Hematopoietic Stem Cell Transplantation 41
- Multiple Myeloma Research and Treatments 28
Public Health, Environmental and Occupational Health 69
- Acute Lymphoblastic Leukemia research 68

Co-authors: Michel Attal (8 shared papers)Thierry Façon (6 shared papers)Philippe Casassus (11 shared papers)Catherine Payen (3 shared papers)Jean‐François Rossi (2 shared papers)Hervé Maisonneuve (2 shared papers)Jean Roy (1 shared paper)Hervé Dombret (54 shared papers)
Journals: Blood (65 papers)Journal of Clinical Oncology (17 papers)Haematologica (17 papers)British Journal of Haematology (11 papers)Leukemia (10 papers)
Partner nations: France United States Switzerland

In The Last Decade

Norbert Ifrah

221 papers receiving 11.2k citations

Norbert Ifrah's Hit Papers

align trajectories log scale

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials 2014 · 479 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet Oncology
1996 New England Journal of Medicine

Peers

Countries citing papers authored by Norbert Ifrah

Since Specialization

Citations

This map shows the geographic impact of Norbert Ifrah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Ifrah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Ifrah more than expected).

Fields of papers citing papers by Norbert Ifrah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Ifrah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Ifrah. The network helps show where Norbert Ifrah may publish in the future.

Co-authors

The 25 scholars most cited alongside Norbert Ifrah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norbert Ifrah Line = papers co-authored together Norbert Ifrah links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 231 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma New England Journal of Medicine ·Michel Attal, Jean Roy, (unknown), (unknown), (unknown), Jean‐François Rossi, Philippe Casassus, Hervé Maisonneuve, Thierry Façon, Norbert Ifrah, Catherine Payen, (unknown) Hit paper breakdown →	1996	1954
2	Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials The Lancet Oncology ·Robert K. Hills, Sylvie Castaigné, Frederick R. Appelbaum, Jacques Delaunay, Stephen H. Petersdorf, Megan Othus, Elihu H. Estey, Hervé Dombret, Sylvie Chevret, Norbert Ifrah, Jean‐Yves Cahn, Christian Récher, Lucy Chilton, Anthony V. Moorman, Alan K. Burnett Hit paper breakdown →	2014	479
3	Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study Journal of Clinical Oncology ·Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, Xavier Thomas, Kheïra Beldjord, Éric Delabesse, Patrice Chevallier, Agnès Buzyn, André Delannoy, Yves Chalandon, Jean‐Paul Vernant, Mårina Lafage‐Pochitaloff, Agnès Chassevent, Véronique Lhéritier, Elizabeth Macintyre, Marie C. Béné, Norbert Ifrah, Hervé Dombret	2009	389
4	Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Blood ·Dorothée Duluc, Yves Delneste, Fang Tan, Marie‐Pierre Moles, Linda Grimaud, Julien Lenoir, Laurence Preisser, Ignacio Anegón, Laurent Catala, Norbert Ifrah, Philippe Descamps, Érick Gamelin, Hugues Gascan, Mohamed Hebbar, Pascale Jeannin	2007	384
5	Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions Clinical Cancer Research ·Laurence Gamelin, M. Boisdron‐Celle, R. Delva, Véronique Guerin‐Meyer, Norbert Ifrah, Alain Morel, Érick Gamelin	2004	259
6	Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia Blood ·Yves Chalandon, Xavier Thomas, Sandrine Hayette, Jean‐Michel Cayuela, Claire Abbal, Françoise Huguet, Emmanuel Raffoux, Thibaut Leguay, Philippe Rousselot, Stéphane Leprêtre, Martine Escoffre‐Barbe, Sébastien Maury, Céline Berthon, Emmanuelle Tavernier, Jean‐François Lambert, Mårina Lafage‐Pochitaloff, Véronique Lhéritier, Sylvie Chevret, Norbert Ifrah, Hervé Dombret	2015	239
7	Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study Blood ·Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet‐Rigal, Éric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean‐Michel Cayuela, Marie-Christine Vekemans, Oumédaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth Macintyre, Véronique Lhéritier, Jean‐Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret	2006	234
8	IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS The Lancet ·D Maraninchi, Didier Blaise, Bernard Rio, V. Leblond, F. Dreyfus, Éliane Gluckman, Denis Guyotat, J L Pico, Mauricette Michallet, Norbert Ifrah, A. Bordigoni	1987	228
9	Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways Blood ·Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet, Sophie Park, Pierre Sujobert, Lise Willems, Norbert Ifrah, François Dreyfus, Patrick Mayeux, Catherine Lacombe, Didier Bouscary	2007	203
10	Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy Journal of Clinical Oncology ·Ibrahim Yakoub‐Agha, Florence Mesnil, Mathieu Kuentz, Jean Michel Boiron, Norbert Ifrah, Nöel Milpied, S Chehata, Hélène Espérou, Jean‐Paul Vernant, Mauricette Michallet, Agnès Buzyn, N Gratecos, J Cahn, Jean Henri Bourhis, Zina Chir, C Raffoux, Gèrard Socié, Jean Louis Golmard, Jean‐Pierre Jouet	2006	189
11	Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments] Blood ·Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J.P. Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah	1992	174
12	TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia Haematologica ·Olivier Kosmider, Véronique Gelsi‐Boyer, Marion Ciudad, Cindy Racoeur, Valérie Jooste, Norbert Vey, Bruno Quesnel, Pierre Fenaux, Jean Bastié, Odile Beyne‐Rauzy, A. Stamatoulas, François Dreyfus, Norbert Ifrah, Stéphane de Botton, William Vainchenker, Olivier Bernard, Daniel Birnbaum, Michaëla Fontenay, Éric Solary, (unknown)	2009	172
13	Correlation Between Uracil and Dihydrouracil Plasma Ratio, Fluorouracil (5-FU) Pharmacokinetic Parameters, and Tolerance in Patients With Advanced Colorectal Cancer: A Potential Interest for Predicting 5-FU Toxicity and Determining Optimal 5-FU Dosage Journal of Clinical Oncology ·Érick Gamelin, M. Boisdron‐Celle, Véronique Guerin‐Meyer, R. Delva, Alain Lortholary, Franck Geneviève, F Larra, Norbert Ifrah, Jacques Robert	1999	167
14	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation Blood ·Alexa S. Green, Nicolas Chapuis, Thiago Trovati Maciel, Lise Willems, Mireille Lambert, Christophe Arnoult, Olivier Boyer, Valérie Bardet, Sophie Park, Marc Foretz, Benoı̂t Viollet, Norbert Ifrah, François Dreyfus, Olivier Hermine, Ivan Cruz Moura, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Jérôme Tamburini	2010	159
15	NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study Blood ·Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, Frédéric Baleydier, Arnauld Simon, Kheïra Beldjord, Oumédaly Reman, Francis Witz, Thierry Fagot, Emmanuelle Tavernier, Pascal Turlure, Thibaut Leguay, Françoise Huguet, Jean‐Paul Vernant, Francis Daniel, Marie C. Béné, Norbert Ifrah, Xavier Thomas, Hervé Dombret, Elizabeth Macintyre	2008	154
16	Comprehensive mutational profiling of core binding factor acute myeloid leukemia Blood ·Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel, Arnaud Petit, Maxime Bucci, Sandrine Geffroy, Hélène Lapillonne, Aline Renneville, Christine Ragu, Martin Figeac, Karine Celli‐Lebras, Catherine Lacombe, Jean‐Baptiste Micol, Omar Abdel‐Wahab, Pascale Cornillet, Norbert Ifrah, Hervé Dombret, Guy Leverger, Éric Jourdan, Claude Preudhomme	2016	150
17	High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study Haematologica ·François Vergez, Alexa S. Green, Jérôme Tamburini, Jean‐Emmanuel Sarry, B. Gaillard, Pascale Cornillet‐Lefèbvre, Mélanie Pannetier, Aymeric Neyret, Nicolas Chapuis, Norbert Ifrah, F. Dreyfus, Stéphane Manenti, Cécile Demur, Éric Delabesse, C. Lacombe, Philip Mayeux, Didier Bouscary, Christian Récher, Valérie Bardet	2011	147
18	PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML Leukemia ·Sophie Park, Nicolas Chapuis, Valérie Bardet, Jérôme Tamburini, Nathalie Gallay, Lise Willems, Zachary A. Knight, Kevan M. Shokat, Nabih Azar, F Viguié, Norbert Ifrah, François Dreyfus, Patrick Mayeux, C. Lacombe, Didier Bouscary	2008	147
19	Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia Blood ·Jérôme Tamburini, Alexa S. Green, Valérie Bardet, Nicolas Chapuis, Sophie Park, Lise Willems, Madalina Uzunov, Norbert Ifrah, François Dreyfus, Catherine Lacombe, Patrick Mayeux, Didier Bouscary	2009	144
20	International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia Haematologica ·Nicola Gökbuget, Hervé Dombret, Josep‐María Ribera, Adele K. Fielding, Anjali S. Advani, Renato Bassan, Victoria Chia, Michael Doubek, Sebastian Giebel, D. Hoelzer, Norbert Ifrah, Aaron J. Katz, Michael A. Kelsh, Giovanni Martinelli, Mireia Morgades, Susan O’Brien, Jacob M. Rowe, Julia Stieglmaier, Martha Wadleigh, Hagop M. Kantarjian	2016	142

About Norbert Ifrah

Norbert Ifrah is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Molecular Biology and Oncology, having authored 231 papers that have together received 11.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (92 papers), Acute Lymphoblastic Leukemia research (68 papers), Chronic Myeloid Leukemia Treatments (44 papers), Hematopoietic Stem Cell Transplantation (41 papers), Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (29 papers), Multiple Myeloma Research and Treatments (28 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers). The work is most often cited by research in Hematology (7.3k citations), Genetics (1.7k citations), Oncology (3.5k citations), Public Health, Environmental and Occupational Health (2.8k citations) and Immunology (1.8k citations). Norbert Ifrah has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Michel Attal, Thierry Façon, Philippe Casassus, Catherine Payen, Jean‐François Rossi, Hervé Maisonneuve, Jean Roy, Hervé Dombret, Nöel Milpied and François Dreyfus. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Norbert Ifrah

Impact in

Papers in i

In The Last Decade

Norbert Ifrah

Norbert Ifrah's Hit Papers

Peers

Countries citing papers authored by Norbert Ifrah

Fields of papers citing papers by Norbert Ifrah

All Works

About Norbert Ifrah

Explore authors with similar magnitude of impact

Papers in